| Investment Objective | |
| An open-ended equity linked savings scheme (ELSS) with the objective of long term growth of capital through a portfolio with a target Investment Objective allocation of 80% equity, 20% debt and money market securities. The Scheme does not guarantee/ indicate any returns. There is no assurance that the objective of the Scheme will be achieved. | |
| Fund Category: ELSS | |
![]() |
|
| Fund Snapshot | |
| Date of Allotment : Mar 29, 1996 | |
| Benchmark:Nifty 500 TRI | |
| Fund Manager - Mr. Dhaval Shah Managing the Fund Since: November 01, 2024 Experience in Managing the Fund: 1.4 Years |
|
| SIP: Monthly: Minimum ₹ 500/- and in multiples of ₹ 500/- thereafter |
|
| Application Amount for fresh subscription: ₹ 500 (plus in multiplies of ₹ 1) |
|
| Minimum Additional Investment: ₹ 500 (plus in multiplies of ₹ 1) |
|
| Load Structure (as % of NAV) (Incl. for SIP) | |
| Entry Load: | NIL |
| Exit Load: | NIL |
| Count of Securities: 62 | |
| AUM as on March 31, 2026 (in ₹Crore) | |
| Month End AUM | 13,117.29 |
| Monthly Average AUM | 13,835.03 |
| Total Expense Ratio (TER) | |
| Regular | 1.69% |
| Direct | 0.96% |
| Including additional expenses and goods and service tax on management fees. | |
| NAV as on March 30, 2026 | |
| Regular Growth | 54.36 |
| Regular IDCW$ | 166.78 |
| Direct Growth | 60.97 |
| Direct IDCW$ | 383.22 |
| $Income Distribution cum capital withdrawal | |
| Valuation Parameters | |
| Average P/E | 23 |
| Average P/BV | 5.4 |
| Average Dividend Yield | 0.96 |
| Top 10 Sectoral Contribution (in %) |
![]() |
| Market Capitalisation |
![]() |
| Volatility Measures | |
| Portfolio Turnover | 0.28 |
| Standard Deviation | 13.75% |
| Sharpe Ratio | 0.38 |
| Beta | 0.92 |
| Treynor Ratio | 0.06 |
| Information Ratio | -0.35 |
Note: Standard Deviation, Sharpe Ratio & Beta are calculated on Annualised basis using 3 years history of monthly returns. Risk Free Rate assumed to be 6.98 % (FBIL Overnight MIBOR as on 30 March, 2026) for calculating SharpeRatio
| Rating Profile of Portfolio | ![]() |
| Sector/Issuer Name | % of Total AUM |
% of Derivatives |
% of Net AUM |
| Equity & Equity Related | |||
| Banks | 24.55 % | ||
| ● ICICI Bank Limited | 7.12 % | ||
| ● HDFC Bank Limited | 6.72 % | ||
| ● Axis Bank Limited | 4.17 % | ||
| ● State Bank of India | 4.11 % | ||
| The Federal Bank Limited | 2.42 % | ||
| IT - Software | 8.10 % | ||
| ● Infosys Limited | 4.85 % | ||
| Tech Mahindra Limited | 2.43 % | ||
| Persistent Systems Limited | 0.83 % | ||
| Finance | 7.88 % | ||
| TVS HOLDINGS LIMTED | 2.42 % | ||
| Bajaj Finance Limited | 1.57 % | ||
| Cholamandalam Investment and Finance Company Limited | 1.39 % | ||
| L&T Finance Limited | 0.95 % | ||
| SBFC Finance Ltd | 0.84 % | ||
| Home First Finance Company India Limited | 0.53 % | ||
| Aditya Birla Capital Limited | 0.18 % | ||
| Retailing | 5.42 % | ||
| Eternal Limited | 2.28 % | ||
| Avenue Supermarts Limited | 1.86 % | ||
| MEESHO LTD | 0.96 % | ||
| Urban Co Ltd | 0.32 % | ||
| Pharmaceuticals & Biotechnology | 4.88 % | ||
| Sun Pharmaceutical Industries Limited | 2.29 % | ||
| Emcure Pharmaceuticals Ltd | 1.64 % | ||
| SAI Life Sciences Ltd | 0.51 % | ||
| Biocon Limited | 0.35 % | ||
| GlaxoSmithKline Pharmaceuticals Limited | 0.09 % | ||
| Petroleum Products | 4.36 % | ||
| ● Reliance Industries Limited | 4.36 % | ||
| Healthcare Services | 4.09 % | ||
| ● Fortis Healthcare Limited | 2.92 % | ||
| Thyrocare Technologies Limited | 0.89 % | ||
| Suraksha Diagnostic Ltd | 0.29 % | ||
| Personal Products | 3.17 % | ||
| Godrej Consumer Products Limited | 1.86 % | ||
| Gillette India Limited | 1.31 % | ||
| Consumer Durables | 3.14 % | ||
| Titan Company Limited | 1.42 % | ||
| Dixon Technologies (India) Limited | 0.90 % | ||
| Whirlpool of India Limited | 0.44 % | ||
| L G Electronics India Ltd | 0.38 % | ||
| Telecom - Services | 2.94 % | ||
| ● Bharti Airtel Limited | 2.94 % | ||
| Power | 2.81 % | ||
| NTPC Limited | 1.60 % | ||
| Adani Power Limited | 1.21 % | ||
| Insurance | 2.68 % | ||
| Max Financial Services Limited | 1.07 % | ||
| Medi Assist Healthcare Services Ltd | 0.81 % | ||
| Go Digit General Insurance Ltd | 0.80 % | ||
| Automobiles | 2.67 % | ||
| ● Mahindra & Mahindra Limited | 2.67 % | ||
| Industrial Products | 2.58 % | ||
| Cummins India Limited | 2.11 % | ||
| Kirloskar Pneumatic Co Ltd | 0.48 % | ||
| Construction | 2.52 % | ||
| ● Larsen & Toubro Limited | 2.52 % | ||
| Transport Infrastructure | 2.50 % | ||
| Adani Ports and Special Economic Zone Limited | 2.50 % | ||
| Non - Ferrous Metals | 2.24 % | ||
| Hindalco Industries Limited | 2.24 % | ||
| Capital Markets | 1.99 % | ||
| Computer Age Management Services Limited | 1.44 % | ||
| Nippon Life India Asset Management Limited | 0.56 % | ||
| Auto Components | 1.60 % | ||
| ZF Commercial Vehicle Control Systems India Limited | 1.60 % | ||
| Beverages | 1.41 % | ||
| Varun Beverages Limited | 1.41 % | ||
| Realty | 1.35 % | ||
| Aditya Birla Real Estate Ltd. | 0.87 % | ||
| Prestige Estates Projects Limited | 0.48 % | ||
| Leisure Services | 1.30 % | ||
| Thomas Cook (India) Limited | 0.73 % | ||
| Chalet Hotels Limited | 0.57 % | ||
| Cement & Cement Products | 1.19 % | ||
| UltraTech Cement Limited | 1.19 % | ||
| Diversified FMCG | 1.00 % | ||
| Hindustan Unilever Limited | 1.00 % | ||
| Agricultural Food & other Products | 0.95 % | ||
| Balrampur Chini Mills Limited | 0.95 % | ||
| Fertilizers & Agrochemicals | 0.79 % | ||
| Sumitomo Chemical India Limited | 0.79 % | ||
| Chemicals & Petrochemicals | 0.78 % | ||
| Vinati Organics Limited | 0.78 % | ||
| Miscellaneous | 0.00 % | Net Cash and Cash Equivalent | 1.10 % |
| Grand Total | 100.00% |
Miscellaneous includes securities with exposure of less than 0.01%
| Product Label | |
| Scheme Name | |
| Aditya Birla Sun Life ELSS Tax Saver Fund An Open ended Equity Linked Saving Scheme with a statutory lock-in of 3 years and tax benefit |
|
| This product is suitable for investors who are seeking*: | |
|
|
Risk-o-meter ![]() |
Benchmark Risk-o-meter Nifty 500 TRI ![]() |
| *Investors should consult their financial advisors if in doubt whether the product is suitable for them. | |